(ARMK) Aramark Holdings - Ratings and Ratios
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US03852U1060
Food Services, Facilities Services, Catering, Vending, Custodial
Dividends
| Dividend Yield | 1.15% |
| Yield on Cost 5y | 1.69% |
| Yield CAGR 5y | -2.97% |
| Payout Consistency | 97.0% |
| Payout Ratio | 23.9% |
| Risk via 10d forecast | |
|---|---|
| Volatility | 26.6% |
| Value at Risk 5%th | 40.8% |
| Relative Tail Risk | -6.72% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.23 |
| Alpha | -17.80 |
| CAGR/Max DD | 0.36 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.448 |
| Beta | 0.846 |
| Beta Downside | 0.858 |
| Drawdowns 3y | |
|---|---|
| Max DD | 27.63% |
| Mean DD | 9.65% |
| Median DD | 9.74% |
Description: ARMK Aramark Holdings October 30, 2025
Aramark Holdings (NYSE: ARMK) delivers food and facilities services across education, healthcare, business & industry, sports & leisure, and corrections markets in the United States and abroad, organized into two reporting segments: Food & Support Services U.S. and Food & Support Services International.
The company’s portfolio includes managed dining, catering, and retail food operations; non-clinical patient nutrition and environmental services; and a suite of facility-management offerings such as custodial, energy management, grounds keeping, and capital-project oversight. It also runs on-site restaurants, vending, concessions, and hospitality services for sports and entertainment venues, plus correctional food, commissaries, and laundry facilities.
Key recent metrics: FY 2023 revenue of $15.4 billion, adjusted EBITDA margin of roughly 7 %, and a contract backlog of about $3.5 billion, indicating a solid pipeline. The business is sensitive to macro drivers such as institutional food-service demand, labor-cost inflation, and commodity price volatility, while the shift toward outsourced non-core services in hospitals and universities supports top-line growth.
For a deeper, data-driven assessment of ARMK’s valuation and risk profile, the ValueRay platform provides a comprehensive dashboard for further research.
Piotroski VR‑10 (Strict, 0-10) 3.5
| Net Income (326.4m TTM) > 0 and > 6% of Revenue (6% = 1.11b TTM) |
| FCFTA 0.03 (>2.0%) and ΔFCFTA 1.06pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue -0.13% (prev -4.64%; Δ 4.51pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.07 (>3.0%) and CFO 921.0m > Net Income 326.4m (YES >=105%, WARN >=100%) |
| Net Debt (5.08b) to EBITDA (1.25b) ratio: 4.07 <= 3.0 (WARN <= 3.5) |
| Current Ratio 0.99 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (267.0m) change vs 12m ago -0.36% (target <= -2.0% for YES) |
| Gross Margin 7.69% (prev 8.19%; Δ -0.51pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 142.5% (prev 137.3%; Δ 5.18pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 2.26 (EBITDA TTM 1.25b / Interest Expense TTM 341.9m) >= 6 (WARN >= 3) |
Altman Z'' 0.53
| (A) -0.00 = (Total Current Assets 3.52b - Total Current Liabilities 3.55b) / Total Assets 13.30b |
| (B) 0.03 = Retained Earnings (Balance) 453.3m / Total Assets 13.30b |
| (C) 0.06 = EBIT TTM 772.4m / Avg Total Assets 12.99b |
| (D) 0.03 = Book Value of Equity 289.0m / Total Liabilities 10.14b |
| Total Rating: 0.53 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 58.98
| 1. Piotroski 3.50pt |
| 2. FCF Yield 3.04% |
| 3. FCF Margin 2.46% |
| 4. Debt/Equity 1.82 |
| 5. Debt/Ebitda 4.07 |
| 6. ROIC - WACC (= 0.57)% |
| 7. RoE 10.59% |
| 8. Rev. Trend 71.62% |
| 9. EPS Trend 56.85% |
What is the price of ARMK shares?
As of December 07, 2025, the stock is trading at USD 37.95 with a total of 1,423,967 shares traded.
Over the past week, the price has changed by +2.43%, over one month by +1.04%, over three months by -1.90% and over the past year by -7.74%.
Over the past week, the price has changed by +2.43%, over one month by +1.04%, over three months by -1.90% and over the past year by -7.74%.
Is ARMK a buy, sell or hold?
Aramark Holdings has received a consensus analysts rating of 4.43.
Therefore, it is recommended to buy ARMK.
- Strong Buy: 8
- Buy: 4
- Hold: 2
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the ARMK price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 44.6 | 17.5% |
| Analysts Target Price | 44.6 | 17.5% |
| ValueRay Target Price | 40.7 | 7.1% |
ARMK Fundamental Data Overview December 05, 2025
Market Cap USD = 9.89b (9.89b USD * 1.0 USD.USD)
P/E Trailing = 30.3226
P/E Forward = 17.0648
P/S = 0.5342
P/B = 3.0945
P/EG = 0.6744
Beta = 1.204
Revenue TTM = 18.51b USD
EBIT TTM = 772.4m USD
EBITDA TTM = 1.25b USD
Long Term Debt = 5.37b USD (from longTermDebt, last quarter)
Short Term Debt = 92.3m USD (from shortTermDebt, last quarter)
Debt = 5.72b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 5.08b USD (from netDebt column, last quarter)
Enterprise Value = 14.97b USD (9.89b + Debt 5.72b - CCE 639.1m)
Interest Coverage Ratio = 2.26 (Ebit TTM 772.4m / Interest Expense TTM 341.9m)
FCF Yield = 3.04% (FCF TTM 454.5m / Enterprise Value 14.97b)
FCF Margin = 2.46% (FCF TTM 454.5m / Revenue TTM 18.51b)
Net Margin = 1.76% (Net Income TTM 326.4m / Revenue TTM 18.51b)
Gross Margin = 7.69% ((Revenue TTM 18.51b - Cost of Revenue TTM 17.08b) / Revenue TTM)
Gross Margin QoQ = 5.78% (prev 8.00%)
Tobins Q-Ratio = 1.13 (Enterprise Value 14.97b / Total Assets 13.30b)
Interest Expense / Debt = 1.57% (Interest Expense 90.0m / Debt 5.72b)
Taxrate = 19.47% (21.1m / 108.3m)
NOPAT = 622.0m (EBIT 772.4m * (1 - 19.47%))
Current Ratio = 0.99 (Total Current Assets 3.52b / Total Current Liabilities 3.55b)
Debt / Equity = 1.82 (Debt 5.72b / totalStockholderEquity, last quarter 3.15b)
Debt / EBITDA = 4.07 (Net Debt 5.08b / EBITDA 1.25b)
Debt / FCF = 11.18 (Net Debt 5.08b / FCF TTM 454.5m)
Total Stockholder Equity = 3.08b (last 4 quarters mean from totalStockholderEquity)
RoA = 2.45% (Net Income 326.4m / Total Assets 13.30b)
RoE = 10.59% (Net Income TTM 326.4m / Total Stockholder Equity 3.08b)
RoCE = 9.13% (EBIT 772.4m / Capital Employed (Equity 3.08b + L.T.Debt 5.37b))
RoIC = 6.82% (NOPAT 622.0m / Invested Capital 9.12b)
WACC = 6.25% (E(9.89b)/V(15.61b) * Re(9.13%) + D(5.72b)/V(15.61b) * Rd(1.57%) * (1-Tc(0.19)))
Discount Rate = 9.13% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 0.50%
[DCF Debug] Terminal Value 76.35% ; FCFE base≈392.3m ; Y1≈444.1m ; Y5≈603.6m
Fair Price DCF = 32.64 (DCF Value 8.58b / Shares Outstanding 262.9m; 5y FCF grow 15.35% → 3.0% )
EPS Correlation: 56.85 | EPS CAGR: 28.90% | SUE: -4.0 | # QB: 0
Revenue Correlation: 71.62 | Revenue CAGR: 6.77% | SUE: -0.12 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.47 | Chg30d=+0.033 | Revisions Net=+8 | Analysts=11
EPS current Year (2026-09-30): EPS=2.21 | Chg30d=-0.073 | Revisions Net=-7 | Growth EPS=+21.6% | Growth Revenue=+6.5%
EPS next Year (2027-09-30): EPS=2.58 | Chg30d=-0.088 | Revisions Net=-5 | Growth EPS=+16.4% | Growth Revenue=+5.9%
P/E Trailing = 30.3226
P/E Forward = 17.0648
P/S = 0.5342
P/B = 3.0945
P/EG = 0.6744
Beta = 1.204
Revenue TTM = 18.51b USD
EBIT TTM = 772.4m USD
EBITDA TTM = 1.25b USD
Long Term Debt = 5.37b USD (from longTermDebt, last quarter)
Short Term Debt = 92.3m USD (from shortTermDebt, last quarter)
Debt = 5.72b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 5.08b USD (from netDebt column, last quarter)
Enterprise Value = 14.97b USD (9.89b + Debt 5.72b - CCE 639.1m)
Interest Coverage Ratio = 2.26 (Ebit TTM 772.4m / Interest Expense TTM 341.9m)
FCF Yield = 3.04% (FCF TTM 454.5m / Enterprise Value 14.97b)
FCF Margin = 2.46% (FCF TTM 454.5m / Revenue TTM 18.51b)
Net Margin = 1.76% (Net Income TTM 326.4m / Revenue TTM 18.51b)
Gross Margin = 7.69% ((Revenue TTM 18.51b - Cost of Revenue TTM 17.08b) / Revenue TTM)
Gross Margin QoQ = 5.78% (prev 8.00%)
Tobins Q-Ratio = 1.13 (Enterprise Value 14.97b / Total Assets 13.30b)
Interest Expense / Debt = 1.57% (Interest Expense 90.0m / Debt 5.72b)
Taxrate = 19.47% (21.1m / 108.3m)
NOPAT = 622.0m (EBIT 772.4m * (1 - 19.47%))
Current Ratio = 0.99 (Total Current Assets 3.52b / Total Current Liabilities 3.55b)
Debt / Equity = 1.82 (Debt 5.72b / totalStockholderEquity, last quarter 3.15b)
Debt / EBITDA = 4.07 (Net Debt 5.08b / EBITDA 1.25b)
Debt / FCF = 11.18 (Net Debt 5.08b / FCF TTM 454.5m)
Total Stockholder Equity = 3.08b (last 4 quarters mean from totalStockholderEquity)
RoA = 2.45% (Net Income 326.4m / Total Assets 13.30b)
RoE = 10.59% (Net Income TTM 326.4m / Total Stockholder Equity 3.08b)
RoCE = 9.13% (EBIT 772.4m / Capital Employed (Equity 3.08b + L.T.Debt 5.37b))
RoIC = 6.82% (NOPAT 622.0m / Invested Capital 9.12b)
WACC = 6.25% (E(9.89b)/V(15.61b) * Re(9.13%) + D(5.72b)/V(15.61b) * Rd(1.57%) * (1-Tc(0.19)))
Discount Rate = 9.13% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 0.50%
[DCF Debug] Terminal Value 76.35% ; FCFE base≈392.3m ; Y1≈444.1m ; Y5≈603.6m
Fair Price DCF = 32.64 (DCF Value 8.58b / Shares Outstanding 262.9m; 5y FCF grow 15.35% → 3.0% )
EPS Correlation: 56.85 | EPS CAGR: 28.90% | SUE: -4.0 | # QB: 0
Revenue Correlation: 71.62 | Revenue CAGR: 6.77% | SUE: -0.12 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.47 | Chg30d=+0.033 | Revisions Net=+8 | Analysts=11
EPS current Year (2026-09-30): EPS=2.21 | Chg30d=-0.073 | Revisions Net=-7 | Growth EPS=+21.6% | Growth Revenue=+6.5%
EPS next Year (2027-09-30): EPS=2.58 | Chg30d=-0.088 | Revisions Net=-5 | Growth EPS=+16.4% | Growth Revenue=+5.9%
Additional Sources for ARMK Stock
News:
Wall Street Journal |
Benzinga |
Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle